Ligelizumab
Product Specifications
UNSPSC Description
Ligelizumab (QGE 031) is a humanized high-affinity monoclonal anti-IgE antibody. Ligelizumab can be used for the research of chronic spontaneous urticarial[1].
Target Antigen
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ligelizumab.html
Purity
99.85
Solubility
H2O
Smiles
[Ligelizumab]
References & Citations
[1]Gasser P, et al. The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab. Nat Commun. 2020 Jan 8;11(1):165.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99300/Ligelizumab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99300/Ligelizumab-SDS-MedChemExpress.pdf
Clinical Information
Phase 3
CAS Number
1322627-61-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6136289-01 0.1 mL
DOCK1 (Dedicator of Cytokinesis Protein 1, 180kD Protein Downstream of CRK, DOCK180) APC
Ask
View Details MBS6136289-02 5x 0.1 mL
DOCK1 (Dedicator of Cytokinesis Protein 1, 180kD Protein Downstream of CRK, DOCK180) APC
Ask
View Details 
MBS1393080-02 0.05 mg (Baculovirus)
Recombinant Rat Collectin-12 (Colec12), partial
Ask
View Details